US approves this Regeneron antibody treatment

Nov 22 2020 02:54 PM
US approves this Regeneron antibody treatment

The corona epidemic crisis in the world is growing even faster. Scientists from many countries are working day and night to develop covid's vaccine. Treatment with antibody drug is being discussed around covid. In the meantime, emergency use of an antibody drug has been approved in the treatment of corona in the US. US health officials have said that the emergency use of an experimental antibody drug Regeneron or REGN-COV2 antibody drug. This antibody-drug was used by President Donald Trump last month when he was Kovid positive. Trump said that this hastened his recovery.

It has been learned that the Food and Drug Administration (FDA) approved the introduction of Regeneron or REGN-COV2 antibodies to patients with mild to moderate symptoms during hospitalization and worsening conditions. The drug can be given only once during treatment through an IV injection. The Food and Drug Administration (FDA) has allowed its use in adults and children over 12 years of age who weigh less than 88 pounds (40 kg) and who are exposed to age or certain other medical conditions. Are at high risk of serious illness since 19.

What is the antibody drug Regeneron ?: According to the information, the antibody drug Regeneron or REGN-COV2 is a combination of two monoclonal antibodies. It has been specifically designed to eliminate or reduce the infection of the covid-spreading virus SARS-CoV-2.

Regeneron reported that the initial dose is to be made available to approximately 300,000 patients through the federal government allocation program. Patients will not be charged for this medication, but may have to pay some part of the cost of delivering the IV. In a way, these drugs were made available to Americans for free.

Also Read:

Russia: 7 people die after consuming sanitizer in party

Corona figures increase in America, records 2 lakh cases a day

Google and Facebook threaten to leave Pakistan over new rules